Close Menu
NCIJ Network NCIJ Network
    What's Hot

    Did NATO cancel summits until Trump leaves office over fears he’ll share intel with Putin?

    November 17, 2026

    Milburn calls for tax cuts for businesses hiring young people despite union concerns | Youth unemployment

    November 17, 2026

    OpenAI Releases GPT-6.2 Astra and Sol With a 20% Cheaper Astra API

    November 17, 2026
    Facebook X (Twitter) Instagram
    Trending
    • Did NATO cancel summits until Trump leaves office over fears he’ll share intel with Putin?
    • Milburn calls for tax cuts for businesses hiring young people despite union concerns | Youth unemployment
    • OpenAI Releases GPT-6.2 Astra and Sol With a 20% Cheaper Astra API
    • Ozempic and Mounjaro may have a surprising effect on your brain
    • Did Llwyneinion lagoon fire cause my husband’s deadly cancer?
    • Jason Clay, who persuaded big business to help save nature, has died at 75
    • AI’s Human Rights Blind Spot
    • What Project 2025 says about the FAA
    • About
      • Our Team
      • Editorial Policy
      • Editorial Independence
      • International Support
    • Trust & Standards
      • AI Usage Policy
      • Conflict of Interest Policy
      • Corrections Policy
      • Ethics Policy
      • Fact-Checking Policy
      • Source Protection
    • Get Involved
      • Guide for Sources
      • Support Independent Journalism
    • Legal
      • Cookie Policy
      • Privacy Policy
      • Terms of Use
    Facebook X (Twitter) Instagram
    NCIJ Network NCIJ Network
    Tuesday, November 17
    • Home
    • World
    • Ai
    • Business
    • Politics
    • Health
    • Crypto
    • Science
    • Technology
    • Cybersecurity
    • Defense & Security
    • Economy
    • Energy
    • Europe
    • More
      • Fact Check
      • Investigations
      • Opinion & Analysis
      • Environment
    NCIJ Network NCIJ Network
    Home»Science

    Ozempic and Mounjaro may have a surprising effect on your brain

    NCIJ NETWNCIJ NETWORKBy NCIJ NETWNCIJ NETWORKNovember 17, 2026 Science No Comments4 Mins Read
    Share
    Facebook Twitter LinkedIn Pinterest Email

    Popular medications used to treat obesity and type 2 diabetes, including semaglutide and tirzepatide, may have effects that extend beyond weight loss and blood sugar control. These drugs also influence biological processes involved in brain function, raising questions about whether they could help preserve memory and thinking abilities.

    To examine this possibility, researchers from the University of Gothenburg and the University of Copenhagen reviewed the existing scientific evidence at the invitation of the journal Science.

    Studies involving animals suggest that GLP-1 medications can influence learning and memory. However, research involving humans has produced less consistent findings. Analyses of patient health records have found an association between GLP-1 treatment and a reduced risk of dementia among people with type 2 diabetes. These observational findings are encouraging, but they cannot determine whether the medications themselves are responsible for the lower risk.

    More definitive results have also raised questions. In Novo Nordisk’s EVOKE and EVOKE+ clinical trials, semaglutide failed to slow the progression of early Alzheimer’s disease. Although the treatment affected several biological markers associated with Alzheimer’s, those changes did not translate into a measurable slowing of the disease.

    Why Weight Loss Drugs May Still Benefit the Brain

    Despite the disappointing Alzheimer’s results, researchers believe GLP-1 medications could still offer cognitive benefits to certain groups of patients.

    People living with obesity or type 2 diabetes sometimes experience difficulties with attention, planning, and the speed at which they process information. These cognitive problems are often associated with metabolic health and blood vessel function, suggesting they may respond differently to treatment than the changes caused by Alzheimer’s disease.

    Improving blood sugar regulation, metabolism, or vascular health could potentially help preserve cognitive abilities, even if the same medications cannot slow an established neurodegenerative disease.

    Stina Börchers, the review’s first author and a researcher affiliated with both the University of Gothenburg and the University of Copenhagen, emphasizes the need to determine whether starting treatment earlier could make a difference.

    “We need to find out whether these treatments can help people with obesity or diabetes preserve their cognitive abilities, particularly if treatment begins before cognitive problems become established. It is also important to identify which patients might benefit,” says Stina Börchers.

    Unlocking New Treatments to Protect Memory

    A central unanswered question is how GLP-1 medications might influence the brain. Their potential cognitive effects could result from improvements in metabolic health, direct actions within the brain, or a combination of both.

    Understanding these mechanisms could help researchers identify which patients are most likely to benefit and potentially lead to medications designed specifically to support memory and other thinking abilities.

    Christoffer Clemmensen, the review’s senior author and a research group leader at the University of Copenhagen, sees an opportunity to use increasingly advanced obesity treatments to explore the connection between metabolism and the brain.

    “Obesity medicines are becoming increasingly sophisticated, offering new opportunities to understand how metabolic regulation influences brain function. By disentangling the direct and indirect effects of these drugs on the brain, we may ultimately be able to develop treatments specifically aimed at preserving cognitive function,” says Christoffer Clemmensen.

    The researchers are calling for clinical trials that evaluate memory, attention, and other cognitive abilities beginning when patients first start treatment. Following these changes over time could help establish whether GLP-1 drugs genuinely protect brain function and clarify who might benefit most.

    They also stress that treatment is not without potential drawbacks, particularly for older adults and people who are physically frail. Rapid weight loss can lead to a reduction in muscle mass, which may weaken physical function and offset some of the possible benefits.

    Careful monitoring will therefore be essential as researchers investigate whether today’s weight loss and diabetes medications could eventually provide new ways to protect the brain.

    brain Effect Mounjaro Ozempic surprising
    NCIJ NETWNCIJ NETWORK
    • Website

    Keep Reading

    William and Catherine celebrate Earthshot Prize winners in Mumbai

    NASA to Cover 35th SpaceX Resupply Mission Space Station Departure

    California Regulators Blamed Brain Injuries Related to Six Flags’ X2 Roller Coaster on Riders — ProPublica

    NICER Status Updates – NASA

    The hidden language of psychopathy is not what scientists expected

    Scientists tracked kids for 8 years. What they found about screen time was surprising

    Add A Comment
    Leave A Reply Cancel Reply

    Editors Picks

    Did NATO cancel summits until Trump leaves office over fears he’ll share intel with Putin?

    November 17, 2026

    Milburn calls for tax cuts for businesses hiring young people despite union concerns | Youth unemployment

    November 17, 2026

    OpenAI Releases GPT-6.2 Astra and Sol With a 20% Cheaper Astra API

    November 17, 2026

    Ozempic and Mounjaro may have a surprising effect on your brain

    November 17, 2026
    Latest Posts

    SmallSat 2026 – NASA Science

    August 20, 2026

    CFTC Chair Says Agency Will Move Forward on Crypto Regulation if CLARITY Fails

    August 20, 2026

    New CUSTODY Framework Constrains AI Agents Inside the Network

    August 20, 2026

    Subscribe to News

    Get the latest sports news from NewsSite about world, sports and politics.

    NCIJ Network is an independent digital news platform delivering trusted investigative journalism, European and global news, in-depth analysis, and fact-based reporting with accuracy, transparency, and integrity.

    Facebook X (Twitter) Instagram Pinterest YouTube

    Did NATO cancel summits until Trump leaves office over fears he’ll share intel with Putin?

    November 17, 2026

    Milburn calls for tax cuts for businesses hiring young people despite union concerns | Youth unemployment

    November 17, 2026

    OpenAI Releases GPT-6.2 Astra and Sol With a 20% Cheaper Astra API

    November 17, 2026

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    Type above and press Enter to search. Press Esc to cancel.